Headache

Featured Article

Erenumab for Episodic Migraine: A Closer Look at the Data

Erenumab for Episodic Migraine: A Closer Look at the Data

For individuals with migraine frequency of 4 to 14 episodes per month, prophylactic medications and analgesics are required.

Latest

Patient Develops Thunderclap Headaches After Consuming 'Carolina Reaper'

Patient Develops Thunderclap Headaches After Consuming 'Carolina Reaper'

The authors note that this appears to be the first case of RCVS secondary to pepper or cayenne ingestion.

Noninvasive Brain Stimulation May Help Prevent Migraines

Noninvasive Brain Stimulation May Help Prevent Migraines

Single-pulse transcranial magnetic stimulation device is safe and easy to use.

Novel Nasal Spray for Migraine Attacks to Be FDA Reviewed

Novel Nasal Spray for Migraine Attacks to Be FDA Reviewed

DFN-02 was evaluated in a multicenter, double-blind, randomized, placebo-controlled study (N=107) which showed it was effective in treating pain and associated symptoms during a migraine attack and in reducing attack-related functional disability.

Sumatriptan Self-Injection System No Longer Available

Sumatriptan Self-Injection System No Longer Available

Sumavel DosePro for the treatment of migraine or cluster headache has been discontinued.

Ubrogepant Effective for Acute Migraine Relief

Ubrogepant Effective for Acute Migraine Relief

Allergan has reported positive results from the first of 2 Phase 3 trials for ubrogepant for the treatment of migraine.

GammaCore Approved for Treatment of Acute Migraine Pain

GammaCore Approved for Treatment of Acute Migraine Pain

The FDA has granted GammaCore 510(k) expanded clearance to treat migraine related pain.

Refractory Migraine Effectively Treated With Erenumab

Refractory Migraine Effectively Treated With Erenumab

Amgen announced that erenumab met its primary endpoint in reducing monthly migraine days.

Migraine, Tension-Type Headache Likely After Exposure to Violence

Migraine, Tension-Type Headache Likely After Exposure to Violence

Prior physical or sexual abuse of survivors increased the likelihood of migraine or tension-type headache.

Coping Questionnaire Helps Assess Migraine Pain

Coping Questionnaire Helps Assess Migraine Pain

The PSEQ successfully shows the debility in migraine surgery patients, and puts migraine pain to perspective.

Migraine Risk Significantly Reduced With Investigational Drug

Migraine Risk Significantly Reduced With Investigational Drug

Patients were randomly assigned to receive eptinezumab (300mg or 100mg) or placebo once every 12 weeks.

Sign Up for Free e-newsletters

CME Focus